Table 1.
FRS 2008 | ATP III‐FRS 2002 | SCORE 2003 | RRS 2007 | Q‐Risk2 2008 | ASCVD 2013 | |
---|---|---|---|---|---|---|
Outcome | Angina, MI, death from CHD, stroke, TIA, peripheral vascular disease, and heart failure | MI, death from CHD | Death from CVD | MI, stroke, coronary revascularization, death from CHD | Angina hospitalization, MI, stroke | MI, stroke, death from CHD |
Sex | + | + | + | + | + | + |
Age | + | + | + | + | + | + |
Ethnicity | + | + | ||||
Chronic disease | + (CKD, RA) | |||||
BMI | + | |||||
Total cholesterol | + | + | + | + | + | |
HDL‐C | + | + | + | |||
TC:HDL‐C ratio | + | + | ||||
LDL‐C | ||||||
Systolic blood pressure | + | + | + | + | + | + |
Smoking status | + | + | + | + | + | + |
Diabetes mellitus | + | + | + | |||
Hypertensive treatment | + | + | + | + | ||
Family history of CAD | + | |||||
hsCRP | + | |||||
Hb A1C | +a |
ASCVD indicates Atherosclerotic Cardiovascular Disease risk score; ATP III‐FRS, Adult Treatment Panel III risk score (a modified FRS); BMI, body mass index; CAD, coronary artery disease; CHD, congestive heart failure; CKD, chronic kidney disease; CVD, cardiovascular disease; FRS, Framingham Risk Score; Hb A1C, hemoglobin A1C; HDL‐C, high‐density lipoprotein cholesterol; hsCRP, high sensitive C reactive protein; LDL‐C, low‐density lipoprotein cholesterol; MI, myocardial infarction; QRISK2, Cardiovascular Disease Risk Algorithm Version 2; RA, rheumatoid arthritis; RRS, Reynolds Risk Score; SCORE, Systematic Coronary Risk Evaluation; TC, total cholesterol; and TIA, transient ischemic attack.
Included if patient has diabetes mellitus.